Tripathy D - Search Results

1

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Tripathy D, Rugo HS, Kaufman PA, Swain S, O'Shaughnessy J, Jahanzeb M, Mason G, Beattie M, Yoo B, Lai C, Masaquel A, Hurvitz S. Tripathy D, et al. BMC Cancer. 2014 May 2;14:307. doi: 10.1186/1471-2407-14-307. BMC Cancer. 2014. PMID: 24885258 Free PMC article. Clinical Trial.

2

Overview: gemcitabine as single-agent therapy for advanced breast cancer.

Tripathy D. Tripathy D. Clin Breast Cancer. 2002 May;3 Suppl 1:8-11. doi: 10.3816/cbc.2002.s.002. Clin Breast Cancer. 2002. PMID: 12057038 Review.

3

Gemcitabine in breast cancer: future directions.

Tripathy D. Tripathy D. Clin Breast Cancer. 2002 May;3 Suppl 1:45-8. doi: 10.3816/cbc.2002.s.010. Clin Breast Cancer. 2002. PMID: 12057046 Review.

4

Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.

Tripathy D, Slamon DJ, Cobleigh M, Arnold A, Saleh M, Mortimer JE, Murphy M, Stewart SJ. Tripathy D, et al. J Clin Oncol. 2004 Mar 15;22(6):1063-70. doi: 10.1200/JCO.2004.06.557. J Clin Oncol. 2004. PMID: 15020607 Clinical Trial.

5

Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer.

Tripathy D, Seidman A, Keefe D, Hudis C, Paton V, Lieberman G. Tripathy D, et al. Clin Breast Cancer. 2004 Oct;5(4):293-8. doi: 10.3816/cbc.2004.n.033. Clin Breast Cancer. 2004. PMID: 15507176 Clinical Trial.

6

Targeted therapies in breast cancer.

Tripathy D. Tripathy D. Breast J. 2005 Mar-Apr;11 Suppl 1:S30-5. doi: 10.1111/j.1075-122X.2005.217166.x. Breast J. 2005. PMID: 15725114 Review.

7

Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.

Melisko ME, Hassin F, Metzroth L, Moore DH, Brown B, Patel K, Rugo HS, Tripathy D. Melisko ME, et al. Among authors: tripathy d. Clin Breast Cancer. 2005 Apr;6(1):45-54. doi: 10.3816/CBC.2005.n.008. Clin Breast Cancer. 2005. PMID: 15899072

8

Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer.

Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D. Rugo H, et al. Among authors: tripathy d. Breast Cancer Res Treat. 2007 Sep;105(1):17-28. doi: 10.1007/s10549-006-9430-6. Epub 2006 Nov 17. Breast Cancer Res Treat. 2007. PMID: 17111207 Clinical Trial.

9

Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials.

Tripathy D. Tripathy D. Oncologist. 2007 Apr;12(4):375-89. doi: 10.1634/theoncologist.12-4-375. Oncologist. 2007. PMID: 17470680 Free article. Review.

10

Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.

Gralow J, Rugo H, Gradishar W, O'Shaughnessy JA, Jahanzeb M, Perez E, Tripathy D. Gralow J, et al. Among authors: tripathy d. Clin Breast Cancer. 2008 Feb;8(1):33-7. doi: 10.3816/CBC.2008.n.046. Clin Breast Cancer. 2008. PMID: 18501057 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

733 results

Search Page

Filters